IScanOr
Skin Screening Device for Early Detection of Cancer
Health Tech & Life Sciences
Non Active, Mar 2022 ceased to operate
Company Overview
Snapshot
Founded in October 2018 by Galit Ankri-Eliahoo and Oren Aharon, IScanOr operates with 1–10 employees. The company is currently in a pre-funding stage, focusing on developing its core technology.
Business overview
IScanOr is a Health Tech & Life Sciences company developing an electronic skin-screening device for the early detection of skin cancer. The device utilizes photonics, optics technologies, sensors, image and data analysis, and AI algorithms to provide a decision-support tool for medical staff in community settings, aiming to enhance the accuracy of skin and mole monitoring. The company operates within the Digital Healthcare and Medical Decision Support sectors, targeting the Israeli market.
Log in to access full profile ›Company Intelligence Q&A
- What is IScanOr's primary focus?
- IScanOr is focused on developing an electronic skin-screening device designed for the early detection of skin cancer, providing a decision-support tool for medical professionals.
- When was IScanOr founded?
- IScanOr was founded in October 2018.
- Who are the founders of IScanOr?
- IScanOr was founded by Galit Ankri-Eliahoo and Oren Aharon.
- What technologies does IScanOr's device utilize?
- The device developed by IScanOr is based on photonics and optics technologies, sensors, image and data analysis, and AI algorithms.
- What is the current operational status of IScanOr?
- IScanOr ceased to operate in March 2022.